A New Way To "Inflation Proof" Your Wealth
When inflation hits an all time high, most investors see gold as a safe haven. However, this unusual investment is seeing 2:1 returns compared to gold. (While still giving you the protection that gold offers)
Click Here To See What It Is

OLMA Insider Trading (Olema Pharmaceuticals)

Insider Ownership Percentage: 23.60%
Insider Buying (Last 12 Months): $30,115,000.00
Insider Selling (Last 12 Months): $2,093,512.67

Olema Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Olema Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Olema Pharmaceuticals Share Price & Price History

Current Price: $23.52
Price Change: Price Decrease of -0.4 (-1.67%)
As of 07/29/2021 01:00 AM ET

This chart shows the closing price history over time for OLMA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

Olema Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/20/2021Cyrus HarmonCTOSell4,123$25.63$105,672.49View SEC Filing Icon  
7/12/2021Kinney HornInsiderSell5,251$26.51$139,204.017,041View SEC Filing Icon  
6/18/2021Cyrus HarmonCTOSell12,000$24.80$297,600.001,102,136View SEC Filing Icon  
6/10/2021Kinney HornInsiderSell5,251$29.72$156,059.727,041View SEC Filing Icon  
5/18/2021Kinney HornInsiderSell57,763$24.15$1,394,976.45View SEC Filing Icon  
11/23/2020Cormorant Asset Management, LpMajor ShareholderBuy425,000$19.00$8,075,000.00View SEC Filing Icon  
11/23/2020G. Walmsley GrahamDirectorBuy1,160,000$19.00$22,040,000.00View SEC Filing Icon  
See Full Table
Insider Trading at Olema Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Olema Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Olema Pharmaceuticals (NASDAQ:OLMA)

87.72% of Olema Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OLMA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Olema Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/22/2021Tybourne Capital Management HK Ltd.239,996$6.72M0.1%-7.7%0.597%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.93,900$3.12M0.0%N/A0.234%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.116,529$3.87M0.0%N/A0.290%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley61,458$2.04M0.0%+34.3%0.153%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC656,126$21.77M0.2%+0.8%1.633%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System18,299$0.61M0.0%N/A0.046%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C271,191$9M0.2%-61.0%0.675%Search for SEC Filing on Google Icon
5/17/2021JS Capital Management LLC12,723$0.42M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada1,101$37K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD8,450$0.28M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/17/2021Janus Henderson Group PLC3,575,568$113.80M0.1%-1.7%8.901%Search for SEC Filing on Google Icon
5/17/2021Ameriprise Financial Inc.465,014$15.43M0.0%+26.8%1.158%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC44,196$1.47M0.0%N/A0.110%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.21,101$0.70M0.0%-61.7%0.053%Search for SEC Filing on Google Icon
5/14/2021Sectoral Asset Management Inc12,900$0.43M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/13/2021Jasper Ridge Partners L.P.14,313$0.48M0.0%N/A0.036%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp32,030$1.06M0.0%N/A0.080%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.1,187$39K0.0%-82.8%0.003%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp130,108$4.32M0.0%+835.9%0.324%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC214,223$7.11M0.0%+708.4%0.533%Search for SEC Filing on Google Icon
5/12/2021Ensign Peak Advisors Inc6,600$0.22M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.100,310$3.33M0.0%+36.5%0.250%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund6,000$0.20M0.0%N/A0.015%Search for SEC Filing on Google Icon
5/11/2021American Financial Group Inc.6,362$0.21M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,453,020$48.21M0.0%+112.2%3.617%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.7,070$0.24M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers10,966$0.36M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/5/2021Hamilton Lane Advisors LLC12,114$0.40M0.1%N/A0.030%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company6,843$0.23M0.0%N/A0.017%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio2,900$96K0.0%N/A0.007%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP43,099$2.07M0.0%N/A0.107%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.73,503$3.53M0.0%N/A0.191%Search for SEC Filing on Google Icon
2/16/2021Orbimed Advisors LLC650,992$31.30M0.3%N/A1.690%Search for SEC Filing on Google Icon
2/16/2021Jefferies Group LLC15,100$0.73M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/16/2021Avoro Capital Advisors LLC876,986$35.65M0.6%N/A2.277%Search for SEC Filing on Google Icon
2/16/2021Avidity Partners Management LP270,000$12.98M0.4%N/A0.701%Search for SEC Filing on Google Icon
2/16/2021Janus Henderson Group PLC3,638,838$160.93M0.1%N/A9.447%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP21,629$1.04M0.0%N/A0.056%Search for SEC Filing on Google Icon
2/13/2021Hillhouse Capital Advisors LTD.620,397$29.83M0.2%N/A1.611%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.260,000$12.50M0.0%N/A0.675%Search for SEC Filing on Google Icon
2/12/2021M&T Bank Corp5,283$0.25M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp13,902$0.67M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.6,912$0.33M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/11/2021Artal Group S.A.260,500$12.53M0.3%N/A0.676%Search for SEC Filing on Google Icon
2/11/2021Tybourne Capital Management HK Ltd.260,000$12.50M0.3%N/A0.675%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.684,709$32.92M0.0%N/A1.778%Search for SEC Filing on Google Icon
2/5/2021SG Americas Securities LLC12,300$0.59M0.0%N/A0.032%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Read More on Olema Pharmaceuticals

Today's Range

Now: $23.52
Low: $22.65
High: $25.53

50 Day Range

MA: $26.68
Low: $22.96
High: $30.51

52 Week Range

Now: $23.52
Low: $19.41
High: $60.27

Volume

212,736 shs

Average Volume

186,142 shs

Market Capitalization

$944.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Olema Pharmaceuticals?

Olema Pharmaceuticals' top insider investors include:
  1. Cyrus Harmon (CTO)
  2. Kinney Horn (Insider)
  3. Cormorant Asset Management, Lp (Major Shareholder)
  4. G Walmsley Graham (Director)

Who are the major institutional investors of Olema Pharmaceuticals?

Olema Pharmaceuticals' top institutional shareholders include:
  1. Tybourne Capital Management HK Ltd. — 0.60%

Which major investors are selling Olema Pharmaceuticals stock?

During the previous quarter, OLMA stock was sold by these institutional investors:
  1. Tybourne Capital Management HK Ltd.
Within the last year, company insiders that have sold Olema Pharmaceuticals company stock include:
  1. Cyrus Harmon (CTO)
  2. Kinney Horn (Insider)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel